Human, Murine & Rat Chemokines
Recombinant Rat MIP-1 beta (CCL4)





 





		Synonyms :
Macrophage Inflammatory Protein-1beta, CCL4, ACT-2



		Description :
Both MIP-1 alpha and MIP-1 beta are structurally and functionally related CC chemokines.  They participate in the host response to invading bacterial, viral, parasite and fungal pathogens by regulating the trafficking and activation state of selected subgroups of inflammatory cells e.g. macrophages, lymphocytes and NK cells.  While both MIP-1 alpha and MIP-1 beta exert similar effects on monocytes their effect on lymphocytes differ; with MIP-1 alpha selectively attracting CD8+ lymphocytes and MIP-1 beta selectively attracting CD4+ lymphocytes.  Additionally, MIP-1 alpha and MIP-1 beta have also been shown to be potent chemoattractants for B cells, eosinophils and dendritic cells.  Both human and murine MIP-1 alpha and MIP-1 beta are active on human and murine hematopoietic cells.  Recombinant rat MIP-1 beta is a 7.8 kDa protein containing 69 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.



		Catalog #:
400-09



		Source :
E.coli



		Purity :
Greater than 98% by SDS-PAGE gel and HPLC analyses.



		Endotoxin Level :
Endotoxin level is less than 0.1 ng per μg (1EU/μg).



		Biological Activity :
Determined by its ability to chemoattract human monocytes using a concentration range of 0.01-1.0 μg/ml.


Selected References :
Selected List of References Citing This PeproTech Product



                AA Sequence :
APIGSDPPTS CCFSYTSRKI HRNFVMDYYE TSSLCSQPAV VFLTKKGRQI CADPSEPWVN EYVNDLELN 



		PubMed Link :
MIP-1beta+AND+rat


Country of Origin :
USA
















        Size A
5μg
$80 
 


 



        Size B
20μg
$195 
 


 



        Size C
1mg
$3000 
 


 















Special 
                    Sizes: 
 Many products can be ordered in custom sizes. Please click here to contact Peprotech with your request.





Usage:
For Research Use Only.  Not for use in diagnostic or therapeutic procedures.